The global neutropenia treatment market size reached US$ 15.3 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 23.8 Billion by 2032, exhibiting a growth rate (CAGR) of 4.9% during 2024-2032. The increasing adoption of cloud platforms, escalating sales of smartphones and extensive research and development (R&D) activities represent some of the key factors d... https://www.imarcgroup.com/neutropenia-treatment-market